Stay updated on Capivasertib+Abiraterone in PTEN-deficient Prostate Clinical Trial
Sign up to get notified when there's something new on the Capivasertib+Abiraterone in PTEN-deficient Prostate Clinical Trial page.

Latest updates to the Capivasertib+Abiraterone in PTEN-deficient Prostate Clinical Trial page
- Check6 days agoChange DetectedThe record history now shows an addition of Revision: v3.4.3 and a deletion of Revision: v3.4.2.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedA new page revision entry 'Revision: v3.4.2' was added to the history, and the previous funding-lapse notice and 'Revision: v3.4.1' were removed.SummaryDifference0.4%

- Check42 days agoChange DetectedA site-wide notice about government funding and a version update to v3.4.1 (replacing v3.4.0) were added. These changes do not affect trial data or navigation on the record page; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check49 days agoChange DetectedThe study history page adds a glossary toggle, color-coded additions and deletions, and a new revision label, representing UI and formatting updates rather than changes to the underlying study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check56 days agoChange DetectedA new revision entry (v3.3.4) was added and the previous revision (v3.3.3) was removed from the history.SummaryDifference0.1%

- Check85 days agoChange DetectedA new revision entry, Revision: v3.3.3, has been added to the history, and the HHS Vulnerability Disclosure item and the Revision: v3.3.2 entry were removed from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Capivasertib+Abiraterone in PTEN-deficient Prostate Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Capivasertib+Abiraterone in PTEN-deficient Prostate Clinical Trial page.